# GLP-1s and Their Impact on Health Equity **Key Points:** – GLP-1s, or glucagon-like peptide-1 receptor agonists, are effective in treating type 2 diabetes and obesity. – While these drugs have shown significant health benefits, they can also be expensive, potentially creating disparities in access to treatment. – Access to GLP-1s may be limited by insurance coverage, high costs, or healthcare provider knowledge. – Promoting health equity requires addressing barriers to access and ensuring that these medications are available to all who can benefit from them. In conclusion, while GLP-1s offer promising benefits for individuals struggling with type 2 diabetes and obesity, it is crucial to consider how access to these treatments can impact health equity. By working towards reducing barriers to access and increasing affordability, we can help ensure that everyone has the opportunity to benefit from these innovative medications. **Contact Mindful Evolution today to learn more about how we can support your weight loss journey. Telehealth services available in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia. Visit our website at https://yourmindfulevolution.com or call/text us at 954-639-9960.** —